- ￥1338 - 11148
- abinScience
- France
- HA089023
- 2026年04月27日
- Mouse
- Human, Mouse
企业认证
相关产品推荐更多 >
Anti-HLA-A2-peptide (FMNKFIYEI) Complex (AMC-48)
￥1338
Anti-Zika Virus Envelope protein E Nanobody (SAA2297)
￥1338
BUB3 Polyclonal Antibody（多克隆抗体）, HRP conjugated | BUB3 Antibody, HRP conjugated | BUB3抗体, HRP conjugated
￥880
UBXN8 Polyclonal Antibody（多克隆抗体）, HRP conjugated | UBXN8 Antibody, HRP conjugated | UBXN8抗体, HRP conjugated
￥880
SOX17 Polyclonal Antibody（多克隆抗体）, FITC conjugated | SOX17 Antibody, FITC conjugated | SOX17抗体, FITC conjugated
￥880
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 亚型：
IgG2a, kappa
- 形态：
Liquid
- 保存条件：
-20°C
- 克隆性：
单克隆
- 适应物种：
Human, Mouse
- 保质期：
twelve months
- 级别：
一抗
- 供应商：
武汉研升生物科技有限公司
- 宿主：
Mouse
- 抗体英文名：
Anti-Human RSPO2 Recombinant Antibody (h130M23-H1L6)
- 规格：
50μg/100μg/1mg
| 规格： | 50μg | 产品价格： | ￥1338.0 |
|---|---|---|---|
| 规格： | 100μg | 产品价格： | ￥2288.0 |
| 规格： | 1mg | 产品价格： | ￥11148.0 |
| 产品名 | Anti-Human RSPO2 Recombinant Antibody (h130M23-H1L6) |
| 货号 | HA089023 |
| 宿主 | Mouse |
| 种属反应性 | Human, Mouse |
| 克隆类型 | Monoclonal |
| 克隆号 | h130M23-H1L6 |
| Accession号 | Q6UXX9 |
| 靶标 | Roof plate-specific spondin-2, R-spondin-2, hRspo2, RSPO2 |
| 同种型 | IgG2a, kappa |
| 应用 | Blocking, in vitro, in vivo, SPR |
| 内毒素水平 | Please contact with the lab for this information. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| 纯度 | >90% as determined by SDS-PAGE. |
| 状态 | Liquid |
| 保存溶液 | 0.01M PBS, pH 7.4. |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 说明 | For research use only. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Recombinant Adenoviruses for In Vivo Expression of Antibody Fragments
A growing number of recombinant antibodies is being developed for immunotherapy of cancer (1 ,2 ) (see also Chapter 2 ). Although these recombinant antibodies can exhibit a potent anti-tumoral activity in vitro, efficacy in vivo
Expression and Isolation of Recombinant Antibody Fragments in E. coli
Central to the rapid growth in the study and application of recombinant antibodies in recent years is the ability to reliably and cost-effectively produce large quantities of functional protein. In contrast to glycosylated whole monoclonal
Preparation of Recombinant Viral Glycoproteins for Novel and Therapeutic Antibody Discovery
Neutralizing antibodies are a critical component in the protection or recovery from viral infections. In the absence of available vaccines or antiviral drugs for many important human viral pathogens, the identification and characterization
技术资料暂无技术资料 索取技术资料
